Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses
Background. Cardiac hypertrophy is one of the initial disorders of the cardiovascular system and can induce heart failure. Oxidative stress is an important pathophysiological mechanism of cardiac hypertrophy. Wogonin (Wog), an important flavonoid derived from the root of Scutellaria baicalensis Geor...
Saved in:
Main Authors: | Xiaowen Shi, Bin Zhang, Zhenliang Chu, Bingjiang Han, Xueping Zhang, Ping Huang, Jibo Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2021/9995342 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
20-HETE mediates Ang II-induced cardiac hypertrophy via ROS and Ca2+ signaling in H9c2 cells
by: Jingyi Han, et al.
Published: (2025-01-01) -
Baicalin Mitigates Cardiac Hypertrophy and Fibrosis by Inhibiting the p85a Subunit of PI3K
by: Lu He, et al.
Published: (2025-01-01) -
Protective effects of wogonin in the treatment of central nervous system and degenerative diseases
by: Qingan Fu, et al.
Published: (2025-02-01) -
Quercetin Inhibits Pyroptosis in Diabetic Cardiomyopathy through the Nrf2 Pathway
by: Zhang Wei, et al.
Published: (2022-01-01) -
Wogonin effects on the efflux transporters BCRP and MRP2, explain its effectiveness in ulcerative colitis: Implications for metabolic and transport interactions
by: Yuanyuan Liu, et al.
Published: (2025-02-01)